Statistics from Altmetric.com
Neovascular glaucoma (NVG) is a severe form of glaucoma usually associated with ischaemic retinal diseases.1 When NVG progresses with extensive retinal ischaemia, not only trabeculectomy or aqueous drainage implants alone but aggressive surgery with multiple procedures (par plana vitrectomy (PPV), endolaser photocoagulation, and simultaneous trabeculectomy) should be considered.2–4 However, surgical outcomes in patients with NVG are disappointing.2–4 Intraoperative bleeding and postoperative inflammation are major obstacles to obtaining longitudinal surgical success.
Bevacizumab (Avastin, Genentech, San Francisco) is a humanised monoclonal antibody against all vascular endothelial growth factor (VEGF) isoforms.5 Bevacizumab, a potent drug that causes rapid regression of iris and retinal neovascularisation, is a powerful adjunct for preventing intraoperative haemorrhage in proliferative diabetic retinopathy.5 6 We report that bevacizumab also can prevent unexpected …
Funding: The study was supported in part by the Research Grants from the Ministry of Education, Science and Culture, Tokyo.
Competing interests: None.
Ethics approval: Ethics approval was provided by the institutional review board.
Patient consent: Obtained.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.